Literature DB >> 9683009

Role of poly(ADP-ribose)synthetase in inflammation.

C Szabó1.   

Abstract

Peroxynitrite and hydroxyl radicals are potent initiators of DNA single strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose)synthetase (PARS). Rapid activation of PARS depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport and ATP formation. This process can result in acute cell dysfunction and cell necrosis. Accordingly, inhibitors of PARS protect against cell death under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARS activation, PARS also appears to modulate the course of inflammation by regulating the expression of a number of genes, including the gene for intercellular adhesion molecule 1, collagenase and the inducible nitric oxide synthase. The research into the role of PARS in inflammatory conditions is now supported by novel tools, such as novel, potent inhibitors of PARS, and genetically engineered animals lacking the gene for PARS. In vivo data demonstrate that inhibition of PARS protects against various forms of inflammation, including zymosan or endotoxin induced multiple organ failure, arthritis, allergic encephalomyelitis, and diabetic islet cell destruction. Pharmacological inhibition of PARS may be a promising novel approach for the experimental therapy of various forms of inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683009     DOI: 10.1016/s0014-2999(98)00249-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

Review 1.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats.

Authors:  Alberto Chiarugi
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.

Authors:  Sevil Korkmaz-Icöz; Bartosz Szczesny; Michela Marcatti; Shiliang Li; Mihály Ruppert; Felix Lasitschka; Sivakkanan Loganathan; Csaba Szabó; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-10-02       Impact factor: 8.739

4.  Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.

Authors:  H C Ha; K Juluri; Y Zhou; S Leung; M Hermankova; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  Use of high-resolution metabolomics for the identification of metabolic signals associated with traffic-related air pollution.

Authors:  Donghai Liang; Jennifer L Moutinho; Rachel Golan; Tianwei Yu; Chandresh N Ladva; Megan Niedzwiecki; Douglas I Walker; Stefanie Ebelt Sarnat; Howard H Chang; Roby Greenwald; Dean P Jones; Armistead G Russell; Jeremy A Sarnat
Journal:  Environ Int       Date:  2018-08-07       Impact factor: 9.621

6.  Poly ADP ribose-polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation.

Authors:  C Sharp; A Warren; T Oshima; L Williams; J H Li; J S Alexander
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

7.  Regulation of the poly(ADP-ribose) polymerase-1 gene expression by the transcription factors Sp1 and Sp3 is under the influence of cell density in primary cultured cells.

Authors:  Karine Zaniolo; Anne Rufiange; Steeve Leclerc; Serge Desnoyers; Sylvain L Guérin
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

8.  Nicotinamide increases systemic vascular resistance in ovine endotoxemia.

Authors:  Marion Scharte; Jerzy-Roch Nofer; Hugo Van Aken; Rene Waurick; Jörg Meyer; Hans-Georg Bone
Journal:  Intensive Care Med       Date:  2003-05-01       Impact factor: 17.440

Review 9.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

10.  Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation.

Authors:  Laura Dugo; Stefania Marzocco; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Achille P Caputi; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.